Clinical Trial

Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis

Completed Phase 3
View on ClinicalTrials.gov →
Summary
A Multicenter, Randomized, Double-blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-01.
Status change: Recruiting → Completed 2026-02-05
Trial Details
NCT Number NCT07111468
Lead Sponsor Yuhan Corporation
Conditions Acute Bronchitis
Enrollment 286 participants
Start Date 2025-08-19
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-01-26 (estimated)
Updated on ClinicalTrials.gov 2026-02-09